학술논문

Revealing molecular pathways for cancer cell fitness through a genetic screen of the cancer translatome
Document Type
article
Source
Cell Reports. 35(13)
Subject
Biochemistry and Cell Biology
Genetics
Biological Sciences
Cancer
1.1 Normal biological development and functioning
Aetiology
Underpinning research
2.1 Biological and endogenous factors
Generic health relevance
5' Untranslated Regions
Animals
Apoptosis
Autophagy
Basic Helix-Loop-Helix Leucine Zipper Transcription Factors
CRISPR-Cas Systems
Cell Line
Tumor
Cell Movement
Cell Proliferation
Eukaryotic Initiation Factor-4E
Exons
Genetic Testing
Genome
Human
Humans
Male
Metalloendopeptidases
Mice
Mitochondria
Mitochondrial Proteins
Neoplasms
Peptide Hydrolases
Protein Biosynthesis
Signal Transduction
Stress
Physiological
bcl-X Protein
Bcl-xL
CRISPRi
EJC
Tfeb
UPR(mt)-like stress response
autophagy
cancer
eIF4E
mitochondria
translation control
Pmpcb
mitochondrial UPR
Medical Physiology
Biological sciences
Language
Abstract
The major cap-binding protein eukaryotic translation initiation factor 4E (eIF4E), an ancient protein required for translation of all eukaryotic genomes, is a surprising yet potent oncogenic driver. The genetic interactions that maintain the oncogenic activity of this key translation factor remain unknown. In this study, we carry out a genome-wide CRISPRi screen wherein we identify more than 600 genetic interactions that sustain eIF4E oncogenic activity. Our data show that eIF4E controls the translation of Tfeb, a key executer of the autophagy response. This autophagy survival response is triggered by mitochondrial proteotoxic stress, which allows cancer cell survival. Our screen also reveals a functional interaction between eIF4E and a single anti-apoptotic factor, Bcl-xL, in tumor growth. Furthermore, we show that eIF4E and the exon-junction complex (EJC), which is involved in many steps of RNA metabolism, interact to control the migratory properties of cancer cells. Overall, we uncover several cancer-specific vulnerabilities that provide further resolution of the cancer translatome.